Pharmadrug Inc.: Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection : vimarsana.com

Established alignment with FDA on the path forward for the development of PD-001, a patented enteric-coated formulation of cepharanthine, towards clinical studies for mild-moderate COVID-19 infectionMeeting

Related Keywords

Saijo , Tokushima , Japan , Germany , United States , Akanaya , Wakayama , South Africa , Toronto , Ontario , Canada , Dejima , Japan General , Zimmerberg , Baden Wüberg , Canadian , South African , German , Daniel Cohen , Van Slyke , Baillyc Cepharanthine , Newsfile Corp , Schedulei European Union , Pharmadrug Inc , European Union , Drug Administration , Breakthrough Designation , Manufacturing Control , Chief Scientific Officer , Middle East , Cepharanthine May Work , Block Coronavirus , Enteric Coated Cepharanthine , Pharmadrug Production Gmbh , Sairiyo Therapeutics , Super Smart , Regarding Forward Looking Information , Drug Repurposing Screens , Pharmadrug , Nnounces , Uccessful , Ompletion , Eeting , Egarding , Roposed , Evelopment , Cepharanthine , Reatment , Ild , Oderate , Ovid , Nfection ,